Friday, May 30, 2014 9:20:37 AM
HTBX Heat Biologics Receives Green Light to Expand Enrollment of Its Phase 1/2 Study of HS-410 in Bladder Cancer Based on Encouraging Preliminary Safety Results http://finance.yahoo.com/news/heat-biologics-receives-green-light-120500050.html?soc_src=mediacontentstory
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
